Delivery Order SPE2DB20D6037-SPE2DB25FTWJ3
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,047.32 firm fixed-price contract is for the delivery of Jardiance 10 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,757.54 contract is for the delivery of Jardiance 10mg tablets over a period ending on November 12, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,162.08 to DMS Pharmaceutical Group Inc. for the supply of Jardiance 25 mg tablets (90-count packages). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery to Conshohocken, Pennsylvania by the August 22, 2025 completion date. This delivery order was awarded without set-aside designation and represents a continuation of DMS...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,141.96, is for the delivery of Jardiance 25 mg tablets. This delivery order is placed under a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999. This IDC, called the SPE2DB program,...
- The Defense Logistics Agency awarded a delivery order valued at $30,010.06 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jardiance 10 mg tablets in quantities of 90. The contract employs a firm fixed-price structure with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4.7 million to DMS Pharmaceutical Group Inc. for 90-count tablets of Jardiance 25 mg, a diabetes medication. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $31,518.19 to DMS Pharmaceutical Group Inc. for 90 tablets of Jardiance 25 mg, a diabetes medication. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive...
- This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $1,913.97, is for the delivery of Jardiance 10 mg tablets. It is a firm fixed-price contract with a completion date of January 17, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,654.30 firm fixed-price contract is for the delivery of Jardiance 25 mg tablets in 90-count packages. The contract has a completion date of July 2, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Jardiance 10 mg tablets. The contract has a potential value of $2,047.32 and a completion date of February 9, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic prescription and...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB25FTWJ3Delivery Order
This delivery order, valued at $5,089.90, awards DMS Pharmaceutical Group Inc. a firm fixed-price contract for Jardiance 10 mg tablets (90-count supply) to support Department of Defense medical supply requirements. The order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025. No set-aside designation was applied to this delivery order. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor and has established itself as a significant supplier within the federal pharmaceutical supply chain since its registration in SAM.gov in 2001. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare facilities nationwide. This delivery order represents a continuation of the vendor's robust portfolio of pharmaceutical product deliveries to the DLA, supporting the agency's mission to supply medical products to Department of Defense healthcare sites globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/11/25 |